USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/1185
Title: Osteoarthrosis: possibilities of complex use of the medication Zeel T within the framework of bioregulatory approach
Authors: Martynchuk, Аlexandr
Popovich, Sergei
Keywords: Zeel T;bioregulatory approach
Issue Date: 2018
Publisher: The Scientific Medical Association of the Republic of Moldova
Citation: MARTYNCHUK, Аlexandr, POPOVICH, Sergei. Osteoarthrosis: possibilities of complex use of the medication Zeel T within the framework of bioregulatory approach. In: The Moldovan Medical Journal. 2018, vol. 61, no 2, pp. 63-66. ISSN 2537-6373.
Abstract: Background: In the article it is considered the essence and possibilities of the bioregulatory approach in the therapy of osteoarthrosis/osteoarthritis (OA) that is realized with the help of the use of complex bioregulatory medications (CBM) of the German company Biologische Heilmittel Heel GmbH. It is described in detail the composition and characteristics of the CBM Zeel T – the chondroprotective compound with a bioregulatory action. Zeel T is registered in the Republic of Moldova as a solution for injections, sublingual tablets and cream. Zeel T contributes to the restoration of the disturbed metabolic and reparative processes in the articular cartilage. There are considered important distinguishable moments of the mechanism of Zeel T action from the traditional chondroprotective compounds and its advantages. It should be noted that Zeel T has more than 40 years research history and it is widely used in more than 30 countries. Every year almost one million patients worldwide are treated with Zeel T. In the article it is presented the overview of clinical studies on the use of Zeel T at OA that demonstrate that Zeel T has comparable clinical efficacy with various traditional medicinal products (MP). Conclusions: It has also a good tolerability, does not cause characteristic for NSAIDs and corticosteroids (CS) side effects, and therefore can be used for a long time. The medicine is well combined with other medicinal products that increases the effectiveness and reduces the duration of the treatment course of OA.
metadata.dc.relation.ispartof: The Moldovan Medical Journal
URI: http://repository.usmf.md/handle/20.500.12710/1185
https://doi.org/10.5281/zenodo.1299039
http://moldmedjournal.md/wp-content/uploads/2019/01/moldmedjournal-2018-61-2-full-issue.pdf
ISSN: 2537-6373
2537-6381
Appears in Collections:The Moldovan Medical Journal, Vol. 61, No 2, June 2018

Files in This Item:
File Description SizeFormat 
63_66_3.pdf1.15 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback